We have historically met our working capital and capital expenditure requirements, including funding for expansion of operations, through net cash flows provided
by operating activities. Our principal source of liquidity is our operating cash flows. Variations in sales of our products would directly affect the availability of funds. There are no material
restrictions on the ability to transfer and remit funds among Herbalife's international affiliated companies.
For
the nine months ended September 30, 2004, we generated $81.0 million from operating cash flows, as compared to $73.1 million in the same period in 2003. The
increase in cash generated from operations reflected (1) a decrease in net income of $12.7 million primarily due to higher interest expense, higher promotional expense and labor costs,
partially offset by increased net sales and the favorable impact of the appreciation of foreign currencies; (2) a decrease of $9.6 million in positive non-cash adjustments to
net income due to lower amortization expense of intangibles in 2004 compared to the high level in 2003 as a result of the final allocation in the third quarter of 2003 of the purchase price in
connection with the Acquisition; (3) an increase in inventory of $19.0 million in 2004 compared to a decrease in inventory of $6.0 million in 2003 related primarily to the
introduction of new products in 2004; (4) an increase in accrued expenses of $30.1 million in 2004 compared to a decrease in accrued expenses of $9.1 million in 2003 primarily due
to higher interest expense accrual of $10.2 million, the majority of which will be paid in the fourth quarter of 2004, increase in non-income tax accruals of $11.3 million
due to higher sales in certain jurisdictions, higher accruals for promotional expenses of $7.7 million due to the eight-month European promotion program and our 25
th
anniversary
promotion which will be paid in the fourth quarter of 2004 and the second quarter of 2005 and (5) an increase in income tax payable of $12.7 million in 2004 compared to a decrease in
income tax payable of $3.0 million in 2003 due primarily to the increase in effective tax rate driven by higher non-deductible interest in 2004.
57
Capital
expenditures, including capital leases for the nine months ended September 30, 2004, were $20.7 million, compared to $15.4 million in the same period in
2003. The majority of these expenditures represented investments in management information systems, internet tools for distributors and office facilities and equipment in the United States. We expect
to incur additional capital expenditures of up to $8.0 million for the remainder of 2004.
In
connection with the Acquisition, we consummated certain related financing transactions including Herbalife International's issuance of its 11
3
/
4
% Notes in the amount of
$165.0 million, and entering into a senior credit facility, consisting of a term loan in the amount of $180.0 million and a revolving credit facility in the amount of
$25.0 million.
The
following summarizes our contractual obligations at September 30, 2004 and the effect such obligations are expected to have on our liquidity and cash flows in future periods:
Payments due by period
Total
2004
2005
2006
2007
2008
2009 &
thereafter
(in millions)
Term Debt
$
66.7
$
4.4
$
17.4
$
17.4
$
17.4
$
10.1
$
11
3
/
4
% Notes
158.3
158.3
9
1
/
2
% Notes
267.9
267.9
Capital Lease
6.7
0.9
3.6
1.9
0.3
Other debt
2.1
0.3
1.2
0.5
0.1
Operating leases
19.0
3.2
9.4
4.4
1.1
0.5
0.4
Total
$
520.7
$
8.8
$
31.6
$
24.2
$
18.9
$
10.6
$
426.6
In
March 2004, we and our lenders amended Herbalife International's existing senior credit facility. Under the terms of the amendment, we made a prepayment of $40.0 million
to reduce outstanding amounts under Herbalife International's senior credit facility. In connection with this prepayment, the lenders under Herbalife International's senior credit facility waived the
March 31, 2004 mandatory amortization payment of $6.5 million along with a mandatory 50% excess cash flow payment for the year ended December 31, 2003. The amendment also lowered
the interest rate to LIBOR plus a 2.5% margin, increased the capital spending allowance under Herbalife International's existing senior credit facility and permitted us to complete a recapitalization.
The schedule of the principal payments was also modified so that we were obligated to pay approximately $4.4 million on March 31, 2004 and in each subsequent quarter through
June 30, 2008.
In
March 2004, Herbalife and its wholly-owned subsidiary WH Capital Corporation completed the $275.0 million offering of the 9
1
/
2
% Notes. The proceeds of the
offering together with available cash were used to pay the original issue price in cash due upon conversion of 104.1 million outstanding Herbalife 12% Series A Cumulative Convertible
preferred shares including 2.0 million warrants exercised in connection with this offering, to pay all accrued and unpaid dividends, to redeem our 15
1
/
2
% Senior Notes and to pay
related fees and expenses. Interest on the 9
1
/
2
% Notes is paid in cash semi-annually in arrears on April 1 and October 1 of each year. The 9
1
/
2
%
Notes are our general unsecured obligations, ranking equally with any of our existing and future senior indebtedness and senior to all of Herbalife's future subordinated indebtedness. Also, the
9
1
/
2
% Notes are effectively subordinated to all existing and future indebtedness and other liabilities of Herbalife's subsidiaries.
Whitney
and Golden Gate (and/or their affiliates) were and are parties to a Share Purchase Agreement (the "Share Purchase Agreement") pursuant to which they originally purchased our
Preferred Shares. Under the terms of the Share Purchase Agreement, Whitney and Golden Gate can, subject to approval by our board of directors and 75% of our shareholders, require us to pay a dividend
to all of our shareholders related to certain income that may be taxable to them resulting from their ownership of our shares. We have recently completed our analysis with regard to this potential
payment and based on this analysis, we may be required to make a $1.4 million payment to our shareholders related to certain income
58
that
may be taxable to them for the year ended December 31, 2003. In addition, we may be required to make a payment to our shareholders related to certain income that may be taxable to them for
the year ended December 31, 2004. We have not yet determined the amount, if any, that could be payable in connection with the 2004 taxes. Both amounts would become distributable to the
shareholders if and when the board of directors and 75% of our shareholders approve the payment of these amounts. As of the date of this filing, our board of directors has not made a determination to
make these distributions. If and when such a determination is made, these amounts will be recorded as dividends.
As
of September 30, 2004, we had working capital of $35.6 million. Cash and cash equivalents were $164.7 million at September 30, 2004, compared to
$150.7 million at December 31, 2003. Simultaneously with our initial public offering, we anticipate closing a series of recapitalization transactions, including:
a
tender offer for any and all of the outstanding 11
3
/
4
% Notes and related consent solicitation to amend the indenture governing the 11
3
/
4
%
Notes;
the
redemption of 40% of our outstanding 9
1
/
2
% Notes;
the
replacement of Herbalife International's existing $205.0 million senior credit facility, under which loans in an aggregate principal amount of
$66.7 million were outstanding on September 30, 2004, with a new $225.0 million senior credit facility;
the
payment of a $109.3 million special cash dividend to our current shareholders subject to upward adjustment in the event that the underwriters exercise their
over-allotment option; and
the
amendment of our memorandum and articles of association to: (1) effect a 1:2 reverse stock split of our common shares; (2) increase our authorized common
shares to 500 million shares; and (3) increase our authorized preference shares to 7.5 million shares.
We
expect that cash and funds provided from operations and available borrowings under our new revolving credit facility will provide sufficient working capital to operate our business,
to make expected capital expenditures and to meet foreseeable liquidity requirements, including debt service on the 9
1
/
2
% Notes and the senior credit facility. There can be no
assurance, however, that our business will service our debt, including our outstanding notes, or fund our other liquidity needs.
The
majority of our purchases from suppliers are generally made in U.S. dollars, while sales to Herbalife distributors generally are made in local currencies. Consequently, strengthening
of the U.S. dollar versus a foreign currency can have a negative impact on operating margins and can generate transaction losses on intercompany transactions. For discussion of our foreign exchange
contracts and
59
other
hedging arrangements, see the quantitative and qualitative disclosures about market risks described below.
Quarterly Results of Operations
All common shares and earnings per share data for the successor gives effect to a 1:2 reverse stock split.
Predecessor
Combined
(1)
Company
Quarter ended
March 31,
2002
June 30,
2002
September 30,
2002
December 31,
2002
March 31,
2003
June 30,
2003
September 30,
2003
December 31,
2003
March 31,
2004
June 30,
2004
September 30,
2004
(in thousands except per share amounts)
Operations:
Net sales
$
265,794
$
281,989
$
272,581
$
273,349
$
280,039
$
288,878
$
290,392
$
300,125
$
324,052
$
324,160
$
319,809
Cost of sales
57,072
62,734
58,892
56,857
56,961
58,401
58,987
61,437
63,618
66,245
68,961
Gross profit
208,722
219,255
213,689
216,492
223,078
230,477
231,405
238,688
260,434
257,915
250,848
Royalty Overrides
94,726
98,643
95,651
98,125
99,510
103,481
104,971
107,389
115,856
114,532
111,978
Marketing, distribution & administrative expenses
81,149
94,598
91,756
81,606
84,376
86,724
111,090
119,072
107,840
105,199
102,772
Acquisition transaction expenses
4,035
50,673
Operating income
32,847
21,979
(24,391
)
36,761
39,192
40,272
15,344
12,227
36,738
38,184
36,098
Interest income (expense), net
575
452
(12,984
)
(10,428
)
(9,947
)
(10,255
)
(11,404
)
(9,862
)
(27,373
)
(14,256
)
(13,604
)
Income before income taxes and minority interest
33,422
22,431
(37,375
)
26,333
29,245
30,017
3,940
2,365
9,365
23,928
22,494
Income taxes
13,369
8,972
(12,198
)
11,110
12,374
12,803
2,241
1,302
9,849
11,840
11,004
Income before minority interest
20,053
13,459
(25,177
)
15,223
16,871
17,214
1,699
1,063
(484
)
12,088
11,490
Minority interest
140
48
Net income
$
19,913
$
13,411
$
(25,177
)
$
15,223
$
16,871
$
17,214
$
1,699
$
1,063
$
(484
)
$
12,088
11,490
Earnings per share
Basic
$
0.62
$
0.41
$
$
$
$
$
$
$
(0.04
)
$
0.23
0.22
Diluted
$
0.60
$
0.39
$
(0.02
)
$
0.30
$
0.32
$
0.32
$
0.03
$
0.02
$
(0.04
)
$
0.22
$
0.21
Weighted average shares outstanding
Basic
32,007
32,591
13,304
52,063
52,265
Diluted
33,291
34,051
51,021
51,021
51,921
53,334
54,392
54,339
54,946
55,066
55,660
(1)
For
the purposes of this presentation we have combined the result of operations of our Predecessor for the period July 1, 2002 through July 31, 2002 and the Company for
the period August 1, 2002 through September 30, 2002. The earnings per share information pertain only to the Company for the period August 1, 2002 through September 30,
2002. Basic and diluted earnings per share for the predecessor for the period July 1 through July 31, 2002 was $(0.73) and $(0.70), respectively.
60
Contingencies
We are from time to time engaged in routine litigation. We regularly review all pending litigation matters in which we are involved and establish reserves deemed
appropriate by management for these litigation matters when a probable loss estimate can be made.
Herbalife
International was a defendant in a purported class action lawsuit in the U.S. District Court of California (
Jacobs v. Herbalife
International, Inc., et al
) originally filed on February 19, 2002 challenging marketing practices of several distributors and Herbalife International under
various state and federal laws. Without in any way admitting liability or wrongdoing, we have reached a binding settlement with the plaintiffs. Under the terms of the settlement, we (i) paid
$3 million into a fund to be distributed to former Supervisor-level distributors who had purchased Newest Way to Wealth materials from the other defendants in this matter, (ii) will pay
up to a maximum aggregate amount of $1 million, refund to former Supervisor-level distributors the amounts they had paid to purchase such Newest Way to Wealth materials from the other
defendants in this matter, and (iii) will offer rebates up to a maximum aggregate amount of $2 million on certain new purchases of Herbalife products to those current Supervisor-level
distributors who had purchased Newest Way to Wealth materials from the other defendants in this matter.
Herbalife
International and certain of its distributors have been named as defendants in a purported class action lawsuit filed July 16, 2003 in the Circuit Court of Ohio County
in the State of West Virginia (
Mey v. Herbalife International, Inc., et al
). Herbalife International had removed the lawsuit to
federal court and the court has recently remanded the lawsuit to state court. The complaint alleges that certain telemarketing practices of certain Herbalife International distributors violate the
Telephone Consumer Protection Act and seeks to hold Herbalife International liable for the practices of its distributors. More specifically, the plaintiffs' complaint alleges that several of
Herbalife's distributors used pre-recorded telephone messages and autodialers to contact prospective customers in violation of the TCPA's prohibition of such practices. Herbalife's
distributors are independent contractors and, if any such distributors in fact violated the TCPA, they also violated Herbalife's policies, which require its distributors to comply with all applicable
federal, state and local laws. We believe that we have meritorious defenses to the suit.
As
a marketer of dietary and nutritional supplements and other products that are ingested by consumers or applied to their bodies, we have been subjected to various product liability
claims. The effects of these claims to date have not been material to us, and the reasonably possible range of exposure on currently existing claims is not material. We believe that we have
meritorious defenses to
the allegations contained in the lawsuits. We currently maintain product liability insurance with an annual deductible of $10.0 million.
Certain
of our subsidiaries have been subject to tax audits by governmental authorities in their respective countries. In certain of these tax audits, governmental authorities are
proposing that significant amounts of additional taxes and related interest and penalties are due. The aggregate amount of asserted taxes, penalties and interest to date is approximately
$34 million. We and our tax advisors believe that there are meritorious defenses to the allegations that additional taxes are owing, and we are vigorously contesting the additional proposed
taxes and related charges.
These
matters may take several years to resolve, and we cannot be sure of their ultimate resolution. However, it is the opinion of management that adverse outcomes, if any, will not
likely result in a material adverse effect on our financial condition and operating results. This opinion is based on our belief that any losses we suffer in excess of amounts reserved would not be
material, and that we have meritorious defenses. Although we have reserved an amount that we believe represents the likely outcome of the resolution of these disputes, if we are incorrect in our
assessment we may have to pay the full amount assessed.